437 related articles for article (PubMed ID: 24925721)
41. Loss of the podocyte-expressed transcription factor Tcf21/Pod1 results in podocyte differentiation defects and FSGS.
Maezawa Y; Onay T; Scott RP; Keir LS; Dimke H; Li C; Eremina V; Maezawa Y; Jeansson M; Shan J; Binnie M; Lewin M; Ghosh A; Miner JH; Vainio SJ; Quaggin SE
J Am Soc Nephrol; 2014 Nov; 25(11):2459-70. PubMed ID: 24904088
[TBL] [Abstract][Full Text] [Related]
42. Glomerular filtration barrier dysfunction in a self-limiting, RNA virus-induced glomerulopathy resembles findings in idiopathic nephrotic syndromes.
Nusshag C; Stütz A; Hägele S; Speer C; Kälble F; Eckert C; Brenner T; Weigand MA; Morath C; Reiser J; Zeier M; Krautkrämer E
Sci Rep; 2020 Nov; 10(1):19117. PubMed ID: 33154421
[TBL] [Abstract][Full Text] [Related]
43. Role of Formyl Peptide Receptors and β-Arrestin-1 in suPAR Signal Transduction in Mouse Podocytes: Interactions with αVβ3-Integrin.
Kim EY; Dryer SE
Cells; 2024 Jan; 13(2):. PubMed ID: 38247863
[TBL] [Abstract][Full Text] [Related]
44. Significance of the urokinase-type plasminogen activator and its receptor in the progression of focal segmental glomerulosclerosis in clinical and mouse models.
Chen JS; Chang LC; Wu CZ; Tseng TL; Lin JA; Lin YF; Cheng CW
J Biomed Sci; 2016 Feb; 23():24. PubMed ID: 26846181
[TBL] [Abstract][Full Text] [Related]
45. Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis.
Otalora L; Chavez E; Watford D; Tueros L; Correa M; Nair V; Ruiz P; Wahl P; Eddy S; Martini S; Kretzler M; Burke GW; Fornoni A; Merscher S
PLoS One; 2019; 14(10):e0222948. PubMed ID: 31581251
[TBL] [Abstract][Full Text] [Related]
46. MiR-30 family prevents uPAR-ITGB3 signaling activation through calcineurin-NFATC pathway to protect podocytes.
Lang Y; Zhao Y; Zheng C; Lu Y; Wu J; Zhu X; Zhang M; Yang F; Xu X; Shi S; Liu Z
Cell Death Dis; 2019 May; 10(6):401. PubMed ID: 31127093
[TBL] [Abstract][Full Text] [Related]
47. Perturbations in podocyte transcriptome and biological pathways induced by FSGS associated circulating factors.
Rashmi P; Sigdel TK; Rychkov D; Damm I; Da Silva AA; Vincenti F; Lourenco AL; Craik CS; Reiser J; Sarwal MM
Ann Transl Med; 2023 Jun; 11(9):315. PubMed ID: 37404982
[TBL] [Abstract][Full Text] [Related]
48. Amiloride off-target effect inhibits podocyte urokinase receptor expression and reduces proteinuria.
Zhang B; Xie S; Shi W; Yang Y
Nephrol Dial Transplant; 2012 May; 27(5):1746-55. PubMed ID: 22076430
[TBL] [Abstract][Full Text] [Related]
49. Mechanisms underlying modulation of podocyte TRPC6 channels by suPAR: Role of NADPH oxidases and Src family tyrosine kinases.
Kim EY; Hassanzadeh Khayyat N; Dryer SE
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3527-3536. PubMed ID: 30293571
[TBL] [Abstract][Full Text] [Related]
50. Rituximab protects podocytes and exerts anti-proteinuric effects in rat adriamycin-induced nephropathy independent of B-lymphocytes.
Takahashi Y; Ikezumi Y; Saitoh A
Nephrology (Carlton); 2017 Jan; 22(1):49-57. PubMed ID: 26833819
[TBL] [Abstract][Full Text] [Related]
51. Dissection of Glomerular Transcriptional Profile in Patients With Diabetic Nephropathy: SRGAP2a Protects Podocyte Structure and Function.
Pan Y; Jiang S; Hou Q; Qiu D; Shi J; Wang L; Chen Z; Zhang M; Duan A; Qin W; Zen K; Liu Z
Diabetes; 2018 Apr; 67(4):717-730. PubMed ID: 29242313
[TBL] [Abstract][Full Text] [Related]
52. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
[TBL] [Abstract][Full Text] [Related]
53. Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report.
Bock ME; Price HE; Gallon L; Langman CB
Clin J Am Soc Nephrol; 2013 Aug; 8(8):1304-11. PubMed ID: 23620441
[TBL] [Abstract][Full Text] [Related]
54. SRGAP1 Controls Small Rho GTPases To Regulate Podocyte Foot Process Maintenance.
Rogg M; Maier JI; Dotzauer R; Artelt N; Kretz O; Helmstädter M; Abed A; Sammarco A; Sigle A; Sellung D; Dinse P; Reiche K; Yasuda-Yamahara M; Biniossek ML; Walz G; Werner M; Endlich N; Schilling O; Huber TB; Schell C
J Am Soc Nephrol; 2021 Mar; 32(3):563-579. PubMed ID: 33514561
[TBL] [Abstract][Full Text] [Related]
55. Podocyte-specific RAP1GAP expression contributes to focal segmental glomerulosclerosis-associated glomerular injury.
Potla U; Ni J; Vadaparampil J; Yang G; Leventhal JS; Campbell KN; Chuang PY; Morozov A; He JC; D'Agati VD; Klotman PE; Kaufman L
J Clin Invest; 2014 Apr; 124(4):1757-69. PubMed ID: 24642466
[TBL] [Abstract][Full Text] [Related]
56. Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease.
Hahm E; Wei C; Fernandez I; Li J; Tardi NJ; Tracy M; Wadhwani S; Cao Y; Peev V; Zloza A; Lusciks J; Hayek SS; O'Connor C; Bitzer M; Gupta V; Sever S; Sykes DB; Scadden DT; Reiser J
Nat Med; 2017 Jan; 23(1):100-106. PubMed ID: 27941791
[TBL] [Abstract][Full Text] [Related]
57. Excess podocyte semaphorin-3A leads to glomerular disease involving plexinA1-nephrin interaction.
Reidy KJ; Aggarwal PK; Jimenez JJ; Thomas DB; Veron D; Tufro A
Am J Pathol; 2013 Oct; 183(4):1156-1168. PubMed ID: 23954273
[TBL] [Abstract][Full Text] [Related]
58. Syndecan-4 ectodomain evokes mobilization of podocyte TRPC6 channels and their associated pathways: An essential role for integrin signaling.
Kim EY; Roshanravan H; Dryer SE
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2610-20. PubMed ID: 26193076
[TBL] [Abstract][Full Text] [Related]
59. Management of severe recurrent focal segmental glomerulosclerosis through circulating soluble urokinase receptor modification.
Morath C; Wei C; Macher-Goeppinger S; Schwenger V; Zeier M; Reiser J
Am J Ther; 2013; 20(2):226-9. PubMed ID: 23466622
[TBL] [Abstract][Full Text] [Related]
60. Dosage-dependent role of Rac1 in podocyte injury.
Wan X; Lee MS; Zhou W
Am J Physiol Renal Physiol; 2016 Apr; 310(8):F777-F784. PubMed ID: 26792065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
